Product News


FDA Approves Infliximab Biosimilar
Infliximab-abda approved for range of gastroenterological and rheumatoid conditions.
Amgen Takes Aim at Sanofi and Regeneron Blockbuster Dupilumab
Already at war over PCSK9, drug giants go to court over another breakthrough drug.
FDA Approves Non-Invasive Stimulation Device for Cluster Headache
Previous studies link vagus nerve stimulation to pain relief for various conditions.
Rigel Submits NDA for Fostamatinib
Company hopes former RA candidate will be approved for rare blood condition.
FDA Approves Injection to Treat All Forms of Diabetic Retinopathy
Ranibizumab can now treat patients with all forms of diabetic retinopathy.
FDA Rejects Lilly's Rheumatoid Arthritis Drug
FDA rejects potential blockbuster, requesting further safety data.
FDA Approves First Drug to Treat Neurological Disorder Tardive Dyskinesia
This FDA approval could relieve patients of several neurological side effects.
FDA Okays Two Hepatitis C Drugs for Pediatric Patients
Two existing hepatitis C drugs can now be used to treat children ages 12-17.
First Direct-to-Consumer Tests for 10 Medical Conditions Win FDA Marketing Approval
These tests could give clues to one's genetic predisposition to some diseases.

Most Popular


$vacMongoViewPlus$ $vAR$